TITLE

HSPVdb-the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands

AUTHOR(S)

Nijveen, Harm; Kester, Michel; Hassan, Chopie; Viars, Aur�lie; Ru, Arnoud; Jager, Machiel; Falkenburg, J.; Leunissen, Jack; Veelen, Peter

PUB. DATE

March 2011

SOURCE

Immunogenetics;Mar2011, Vol. 63 Issue 3, p143

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

T cell epitopes derived from polymorphic proteins or from proteins encoded by alternative reading frames (ARFs) play an important role in (tumor) immunology. Identification of these peptides is successfully performed with mass spectrometry. In a mass spectrometry-based approach, the recorded tandem mass spectra are matched against hypothetical spectra generated from known protein sequence databases. Commonly used protein databases contain a minimal level of redundancy, and thus, are not suitable data sources for searching polymorphic T cell epitopes, either in normal or ARFs. At the same time, however, these databases contain much non-polymorphic sequence information, thereby complicating the matching of recorded and theoretical spectra, and increasing the potential for finding false positives. Therefore, we created a database with peptides from ARFs and peptide variation arising from single nucleotide polymorphisms (SNPs). It is based on the human mRNA sequences from the well-annotated reference sequence (RefSeq) database and associated variation information derived from the Single Nucleotide Polymorphism Database (dbSNP). In this process, we removed all non-polymorphic information. Investigation of the frequency of SNPs in the dbSNP revealed that many SNPs are non-polymorphic 'SNPs'. Therefore, we removed those from our dedicated database, and this resulted in a comprehensive high quality database, which we coined the Human Short Peptide Variation Database (HSPVdb). The value of our HSPVdb is shown by identification of the majority of published polymorphic SNP- and/or ARF-derived epitopes from a mass spectrometry-based proteomics workflow, and by a large variety of polymorphic peptides identified as potential T cell epitopes in the HLA-ligandome presented by the Epstein-Barr virus cells.

ACCESSION #

57941997

Tags: PEPTIDES;  BIOCHEMICAL variation;  MASS spectrometry;  HLA histocompatibility antigens;  LIGANDS (Biochemistry);  PROTEOMICS;  ANTIGENIC determinants

 

Related Articles

• Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength. Lund, Ole; Nascimento, Eduardo J. M.; Maciel, Jr, Milton; Nielsen, Morten; Larsen, Mette Voldby; Lundegaard, Claus; Harndahl, Mikkel; Lamberth, Kasper; Buus, Søren; Salmon, Jérôme; August, Thomas J.; Marques, Jr, Ernesto T. A. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

  -Epitopes from all available full-length sequences of yellow fever virus (YFV) and dengue fever virus (DENV) restricted by Human Leukocyte Antigen class I (HLA-I) alleles covering 12 HLA-I supertypes were predicted using the NetCTL algorithm. A subset of 179 predicted YFV and 158 predicted DENV...

• Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Zhang, Hao; Lundegaard, Claus; Nielsen, Morten // Bioinformatics;Jan2009, Vol. 25 Issue 1, p83 

  Motivation: MHC:peptide binding plays a central role in activating the immune surveillance. Computational approaches to determine T-cell epitopes restricted to any given major histocompatibility complex (MHC) molecule are of special practical value in the development of for instance vaccines...

• Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Lemmel, Claudia; Weik, Steffen; Eberle, Ute; Dengjel, J�rn; Kratt, Thomas; Becker, Horst-Dieter; Rammensee, Hans-Georg; Stevanovic, Stefan // Nature Biotechnology;Apr2004, Vol. 22 Issue 4, p450 

  Currently, no method allows direct and quantitative comparison of MHC-presented peptides in pairs of samples, such as transfected and untransfected, tumorous and normal or infected and uninfected tissues or cell lines. Here we introduce two approaches that use isotopically labeled reagents to...

• Prediction of promiscuous peptides that bind HLA class I molecules. Brusic, Vladimir; Petrovsky, Nikolai; Zhang, Guanglan; Bajic, Vladimir B // Immunology & Cell Biology;Jun2002, Vol. 80 Issue 3, p280 

  Summary Promiscuous T-cell epitopes make ideal targets for vaccine development. We report here a computational system, multipred, for the prediction of peptide binding to the HLA-A2 supertype. It combines a novel representation of peptide/MHC interactions with a hidden Markov model as the...

• Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Greenbaum, Jason; Sidney, John; Chung, Jolan; Brander, Christian; Peters, Bjoern; Sette, Alessandro // Immunogenetics;Jun2011, Vol. 63 Issue 6, p325 

  Previous studies have attempted to define human leukocyte antigen (HLA) class II supertypes, analogous to the case for class I, on the basis of shared peptide-binding motifs or structure. In the present study, we determined the binding capacity of a large panel of non-redundant peptides for a...

• Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors. Andersen, Rikke; S�rensen, Rikke; Ritter, Cathrin; Svane, Inge; Becker, J�rgen; thor Straten, Per; Andersen, Mads // Cancer Immunology, Immunotherapy;Feb2011, Vol. 60 Issue 2, p227 

  With the aim to identify cyclin B1-derived peptides with high affinity for HLA-A2, we used three in silico prediction algorithms to screen the protein sequence for possible HLA-A2 binders. One peptide scored highest in all three algorithms, and the high HLA-A2-binding affinity of this peptide...

• Hepatitis C Virus--Derived Lipopeptides Differentially Induce Epitope-Specific Immune Responses In Vitro. Langhans, Bettina; Schweitzer, Susann; Nischalke, Hans Dieter; Braunschweiger, Ingrid; Sauerbruch, Tilman; Spengler, Ulrich // Journal of Infectious Diseases;1/15/2004, Vol. 189 Issue 2, p248 

  We studied the induction of T cell responses against hepatitis C virus (HCV)-related cytotoxic T cell (CTL) epitopes in lymphocytes from human leukocyte antigen (HLA)-A2-positive, HCV-naive individuals. Peptide and lipopeptides corresponding to the epitope at amino acids (aa) 1073-1081 induced...

• Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients. Ravindranath, Mepur H.; Pham, Tho; Ozawa, Miyuki; Terasaki, Paul I. // International Immunology;Jan2012, Vol. 24 Issue 1, p43 

  The non-donor-specific anti-HLA-Ia antibodies correlate significantly with lower graft survival in organ transplant patients. Based on our earlier findings that anti-HLA-E murine monoclonal antibodies (MEM-E/02 and 3D12) reacted with different HLA-Ia alleles and the peptides shared by HLA-E and...

• Characterization of MHC Ligands for Peptide Based Tumor Vaccination. Klug, Felix; Miller, Matthias; Schmidt, Hans-Henning; Stevanovic, Stefan // Current Pharmaceutical Design;10/1/2009, Vol. 15 Issue 28, p3221 

  Short peptides derived from cellular proteins may escape complete destruction during protein catabolism and finally serve as a showcase in the immune system. Exposed at the cell surface to scrutiny by T cells, MHC:peptide complexes mediate a highly specific and immediate information transfer...

Read the Article